In recent years, a cross-sectional study of patients with T2D showed that IL-18 levels were significantly boosted at a low eGFR and positively correlated with the development of DN and urinary albumin excretion (UAE) rate (111, 112). The gene discussed is ALB; the disease is liver dysplastic nodule.